MHIP Stock: Earnings, Dividends & Analyst Estimates

Company Overview:

Market Cap: $1.02M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $19.45 - $22.57

0.4 Year MHIP Performance Metrics:

Total Return (with DRIP): 4.0% (10.28% CAGR)

Total Return (no DRIP): 4.0% (10.28% CAGR)

Share Price: 4.0% (10.28% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $10,399

Total Return $ (with DRIP): $399

MHIP Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

MHIP Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for MHIP

Based on past 0.4-year performance, here are MHIP growth metrics:

Share price CAGR of +10.28%
Dividend CAGR of +0%

Using MHIP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	MHIP (DRIP)	MHIP - No DRIP
Current Price	$20.59	$20.59
Start Shares	485.67	485.67
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	485.67	485.67
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$20.59	$20.59
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - MHIP

NOTE: Above numbers are our estimate based on MHIP's Dividend and Price CAGR over past 0.4 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Milliman Healthcare Inflation Plus ETF (MHIP) had its IPO on 2026-04-21, and is traded on AMEX stock exchange.

The Milliman Healthcare Inflation Plus ETF (MHIP) is designed to shield and enhance investors' purchasing power against the backdrop of escalating medical expenditures. This is accomplished by leveraging proprietary actuarial data and sophisticated quantitative modeling. The fund’s analytical framework relies on Milliman's extensive database of actual healthcare claims, encompassing approximately 35 million insured individuals, to project future healthcare inflation through the examination of medical and pharmacy cost trajectories. Its investment portfolio encompasses both equity and fixed income securities spanning the entire healthcare supply chain, augmented by various inflation-hedging instruments such as commodities, Treasury Inflation-Protected Securities (TIPS), and conventional Treasury bonds. Typically, the MHIP portfolio undergoes monthly rebalancing, guided by a quantitative model that dynamically adjusts to shifts in US healthcare cost inflation. Specifically, the strategy increases its exposure to equities and commodities during periods of elevated inflation, conversely pivoting towards debt instruments when inflation levels are lower. The fund's holdings may further include derivative products like swaps, options, and futures contracts, as well as exchange-traded funds (ETFs).

MHIP website: https://www.millimanfunds.com